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Abstract: Migraine is a neurological disorder that correlates with an increased risk of cerebrovascular lesions. Genetic 
mutations of the MTHFR gene are correlated to migraine and to the increased risk of artery pathologies. Also, migraine 
patients show altered hematochemical parameters, linked to an impaired platelet aggregation mechanism. Hence, the 
vascular assessment of migraineurs is of primary importance. 
Transcranial Doppler sonography (TCD) is used to measure cerebral blood flow velocity (CBFV) and vasomotor 
reactivity (by an index measured during breath-holding – BHI). Aim of this study was the metabolic profiling of migraine 
subjects with T/T677-MTHFR and C/T677-MTHFR mutations and its correlation with CBFV and BHI. 
Metabonomic multidimensional techniques were used to describe and cluster subjects. Fifty women suffering from 
migraine (age: 18-64; 21 with aura) underwent TCD examination, hematochemical blood analysis, Born test, and genetic 
tests for MTHFR mutation. Fourteen (7 with aura) had T/T677, 18 (8 with aura) had C/T677, and 18 (6 with aura) had no 
mutation. The total number of variables was 24. 
Unsupervised and supervised techniques showed the correlation between CBFV and BHI with mutation. Discriminant 
analysis allowed for classifying the subjects with 95.9% sensitivity and 89.0% specificity. Aura was not correlated to 
mutation or variations of instrumental data. 
Our study showed that metabonomics could be effectively applied in clinical problems to show the overall correlation 
structure of complex systems in pathology. Specifically, our results confirmed the importance of TCD in the metabolic 
profiling and follow-up of migraine patients. 
Keywords: Metabonomics, migraine, genetic mutations, PCA, PLS, classification, MTHFR, data mining, transcranial Doppler 
sonography. 
1. INTRODUCTION 
 Migraine is a neurological disorder that correlates with 
an increased risk of subclinical cerebral vascular lesions [1]. 
Subjects suffering from migraine with aura (MwA) are 
particularly exposed to such a vascular risk [2]. There is a 
trend in considering migraine as a systemic vasculopathy [3]. 
The relationship between migraine with aura and cerebral 
lesions is not fully known, but it seems that the increased 
vascular risk of the migraineurs is not caused by the 
traditional risk factors (i.e., hypertension, hyperglycemia, 
hypercholesterolemia, …) [2]. However, the above-
mentioned factors have implications on the possible drug 
therapies administered to migraine sufferers. 
 It has been demonstrated that migraine is associated to 
alterations in some hematochemical parameters related to 
platelet aggregation [4, 5]. The biological response to some  
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agents acting on platelet function has been found altered in 
women suffering from migraine: adenosine diphosphate, 
collagen, ristocetin, epinephrine, prostacyclin, arachidonic 
acid, and 5-hydro-triptamine [6]. These alterations could 
increase the risk of vascular diseases on a thrombotic base. 
 Another important alteration that was correlated to MwA 
is the increase in the concentration of homocysteine. This 
amino acid, which is linked to the metabolism of the B6 and 
B12 vitamins, represents a powerful risk factor for 
cardiovascular diseases when highly concentrated in blood 
serum [7, 8]. The genetic mutation T/T 677 in homozygosis 
of the genotype 677-MTHFR (methylenetetrahydrofolate 
reductase) may cause increased levels of blood 
homocysteine. This mutation has been correlated to MwA 
[9] and to an increment in the angiopathies due to oxidative 
stress [10]. Recent studies proved that the T/T 677 mutation 
correlates to hyperhomocysteinemia, peripheral arteries 
pathologies [11], and cardiovascular events in presence of 
hypertension [12]. Therefore, due to the possible vascular 
implications they carry, genetic mutations in MwA are being 
more and more studied. 
24    The Open Medical Informatics Journal, 2010, Volume 4 Giustetto et al. 
 Given the correlation between migraine and vascular 
disorders, migraine sufferers usually undergo assessment of 
the cerebrovascular status. The transcranial Doppler 
sonography (TCD) is a non-invasive and reliable technique 
to measure the cerebral blood flow velocity (CBFV) in the 
arteries of the macro-circulation [13]. Some Authors 
evidenced that MwA patients present altered CBFV values 
compared to healthy controls, both in resting conditions [14] 
and in reactivity maneuvers [15]. The assessment of cerebral 
vasomotor reactivity (i.e., the arteries’ capacity of 
compensating systemic blood pressure alterations) is of 
primary importance to assess the overall status of the artery 
bed. Despite this, the clinical utility of TCD in diagnosis and 
follow-up of migraine sufferers is still debated. 
 The aims of this study were: 1) to test the importance of 
TCD examinations in migraine sufferers by studying the 
correlations of CBFV with hematochemical and genetic 
parameters; 2) to develop a classifier for the detection of the 
677-MTHFR genotype based on hematochemical parameters 
and instrumental data (i.e., TCD analysis). 
 We studied a population of female migraineurs. We 
applied metabonomic techniques to a database consisting of 
metabolic and hematochemical data, genetic data, and 
instrumental data coming from Doppler clinical analyses. 
Metabonomics, which belongs to the “-omics” sciences, 
quantitatively measures living systems undergoing the 
effects of diseases of genetic mutations. Unlike genomics 
and proteomics, metabonomics focuses on the 
multiparameter evaluation of a living complex system by 
studying its overall physiological profile. In this study, we 
combined unsupervised and supervised analysis techniques. 
The final result of unsupervised techniques is not guided by 
the maximization of externally imposed classification goals 
(i.e., discrimination between normal and pathologic, or 
placebo vs drug administration, or different classes of 
disease). Rather, unsupervised techniques maximize the 
overall perception of the data set feature by minimizing the 
number of variables used to represent them. Therefore, 
unsupervised techniques allow for an unbiased description of 
the natural correlation structure in the data set. Conversely, 
supervised methods aim at maximizing an externally 
imposed task, such as the separation of a-priori defined 
classes. Given the difficulty of the task and the biological 
variability we expected in this study, we combined 
unsupervised and supervised techniques: the unsupervised 
approach was used to drive the supervised analysis. We used 
the principal component analysis (PCA) as unsupervised 
technique, and the partial least squares - discriminant 
analysis (PLS-DA) as supervised approach. 
2. MATERIALS AND METHODS 
2.1. Description of the Database 
 We considered in this study 50 women suffering from 
migraine, diagnosed following the criteria of the 
International Headache Society [16], that were consecutively 
admitted to the observation of the Women’s Headache 
Center of the University of Torino (Italy). The mean age of 
the patients was 38.5 ± 1.6 years (range: 18 – 64 years). 
Twenty-one patients suffered from MwA. The patients were 
referred to the Neurology Division of the Gradenigo Hospital 
of Torino (Italy), where all the instrumental analyses (i.e., 
TCD examinations) were carried out. Exclusion criteria were 
the presence of headache other than migraine or of chronic 
metabolic diseases. 
 All the subjects were informed about the purpose of the 
study and about data acquisition and treatment. All patients 
signed an informed consent before entering the study. The 
local Institutional Review Board approved this research. 
 In the following we describe in detail the database. In the 
description, we separate instrumental data (subsection 2.1.1), 
hematochemical data (subsection 2.1.2), and genetic data 
(2.1.3). To the best of our knowledge, this is the only study 
that considers a mixed database consisting of metabolic, 
clinical, and instrumental variables. 
2.1.1. TCD Data 
 All the subjects underwent TCD examination of the 
middle cerebral arteries (MCA). No subjects were discarded 
due to poor bone window. We used a commercially available 
TCD device (X4 MultiDop, DWL, Germany) equipped by 
two 2 MHz ultrasound probes. The probes were placed in 
correspondence of the temporal window and were firmly 
held in place by using an apposite holder. The same operator 
(a sonographist with more than 30 years of experience in 
vascular ultrasounds) performed all the examinations. We 
measured the CBFV in the M1 tract of the subjects’ MCAs. 
 The TCD recording took place in a quiet and dimmed 
room, with the subjects lying in a supine and comfortable 
position, and breathing room air. All the TCD examinations 
were carried out in the interictal period, so that the subjects 
were free of pain. After 5 minutes of baseline recording, the 
subjects were asked to hold the breath. Breath – holding 
(BH) is a powerful stimulus that induces vasodilation in the 
cerebral arteries [17]. Vasodilation causes a drop in the 
resistance of the peripheral vessels, thus increasing cerebral 
blood flow. The measurement of the CBFV variation during 
BH is effective in assessing the cerebral vascular status of 
the subject [18]. We measured the vasomotor reactivity by 
using the breath – holding index (BHI), which is defined as: 
BHI =
VBH VBASE
VBASE
*100             (1) 
where: 
• VBH  represents the CBFV measured at the end of the 
BH and averaged on a 60-seconds time window; 
• VBASE  represents the CBFV measured at the beginning 
of the BH and averaged on a 60-second time window. 
 It has been shown that in the population of MwA 
sufferers there is an increased percentage of cardiac atrial 
septal defects, including patent foramen ovale (PFO) [19, 
20]. PFO has been indicated as one of the possible causes of 
cerebrovascular accidents affecting MwA sufferers. 
Therefore, we considered the presence of emboli in the 
intracranial circulation as an index of cerebrovascular risk. 
 When a blood cloth flows in the insonated cerebral 
artery, it produces a characteristic signal called “high-
intensity transient signal” (HITS). The TCD device we used 
was equipped by an automated HITS detection algorithm. 
We measured the number of the detected HITS in both the 
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MCAs and inserted these numbers into the instrumental 
variables set. 
 Finally, in a previous study conducted on a relatively 
large sample population of Italian women, we showed that 
CBFV decreases with age [21]. Therefore, we also 
considered age as a variable in our database. Table 1 
summarizes the six instrumental variables (plus age) that we 
used in this study. 
Table 1. TCD Data. TCD Data (with Unit) that were Inserted 
in the Database 
 
Variable Unit 
Age year 
Left CBFV cm/s 
Right CBFV cm/s 
Left BHI % 
Right BHI % 
Left HITS a.u. 
Right HITS a.u. 
 
2.1.2. Hematochemical Data 
 The same laboratory made all the hematological 
analyses. The subjects were asked to undergo blood analysis 
within 2 days from the TCD examination. Since our purpose 
was to develop a methodology based on data that are usually 
acquired during migraine treatment protocols, we roughly 
kept the same list of blood analysis that was routinely used at 
the Women’s Headache Center of Torino (Italy). Table 2 
reports the complete list of variables we considered. The first 
column reports the hematochemical variables. The patients 
underwent the Born test for platelet aggregation under the 
effect of some agents [22]. The list of agents we considered 
is reported by the second column of Table 2. 
2.1.3. Genetic Data 
 All the patients were asked to undergo a genetic test to 
discover possible mutations of the 677-MTHFR genotype. 
The C/T677-MTHFR variant (leading to an alanine to valine 
substitution) results in a thermolabile enzyme and decreased 
production of folate, which is a cofactor required for 
homocysteine remethylation. Homozygosity for the 677-
MTHFR variant is associated with hyperhomocysteinemia 
up to 50% higher than normal. The testing methodology was 
Direct Mutation Analysis: an automated high-throughput 
system incorporating DNA amplification (PCR), primer 
extension, and allele resolution by Matrix Assisted Laser 
Desorption Ionization-Time of Flight (MALDI-TOF) Mass 
Spectrometry was used to test for variants in the MTHFR 
gene. 
 The genetic test revealed 14 subjects with T/T677-
MTHRF mutation, 18 with C/T677-MTHFR mutation, and 
18 with no mutation. Seven patients with T/T677 mutation, 
eight with C/T677 mutation, and six with no mutation 
suffered from MwA. 
 
Table 2. Data from Hematochemical Analysis and Born Test 
(Biochemical Data). The First Column of the Table 
Reports the Hematochemical Data (with Unit) that 
were Inserted in the Database. The Second Column 
of the Table Reports the Agents we Considered for 
the Platelet Aggregation Response (Born Test) (the 
Response is Given in Percentage) 
 
Hematochemical Variable 
Agents for Platelet  
Aggregation Test (Born Test) 
Antithrombin (%) Arachidonic Acid (%) 
Activated partial  
thromboplastin time (APTT) (s) 
Adenosine diphosphate (ADP)  
(1 micromolar) – ADP1 (%) 
Hemoglobin (g/dl) Collagen (2 micromolar) (%) 
Erythrocytes (x1000000/) Ristocetine (%) 
Fibrinogen (mg/dl) Arachidonic Acid (%) 
Leucocytes (x1000/l)  
Platelets (x1000/l)  
C Protein (%)  
S Protein (%)  
Prothrombin (%)  
Prothrombin time in International  
Normalized Ratio – Ptinr (a.u.) 
 
Activated partial  
thromboplastin time (APTT) (s) 
 
 
2.2. Statistical Analysis 
 Multivariate analysis was applied to the data set 
constituted by the above-described variables. The raw data 
set was a matrix having as rows (statistical units) 50 patients 
and as columns (variables) the 24 values relative to the 
hematochemical, instrumental, and genetic exams. 
 We used an analysis strategy combining 
multidimensional ANOVA analysis, unsupervised analysis, 
supervised analysis and classification. The entire database 
was first analyzed by using ANOVA and unsupervised 
techniques, in order to extract the correlation structure that 
constitutes the inner texture of the data. We considered the 
mutation type and the presence or absence of aura as 
principal factors. The right and left CBFVs were considered 
as dependent variables. We used ANOVA to detect the most 
significant variables for the dependent variables. This helped 
us in reducing the problem complexity and representation. 
Subsequent unsupervised and supervised techniques were 
then conducted on a reduced variables set, in order to better 
detail the inner correlation structure of the data set. 
 To build the classifier, the raw data set was then split in 
two parts. This procedure is known as cross-validation. We 
decided to use it in order to avoid possible over fitting of the 
data set given by the relatively small number of patients. 
 All the statistical analyses were carried out by using 
StatGraphics Centurion XV. In the following, we briefly 
explain the analysis techniques we used in this research. 
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2.2.1. Multidimensional Analysis and Outlier Rejection 
 Prior of performing unsupervised and supervised 
clustering, we performed a multivariate analysis of the raw 
data. Specifically, we aimed at evidencing the variables that 
are linked to genetic mutation in migraine. 
 In a previous study, we demonstrated that the left and 
right CBFV of healthy women are highly correlated [21]. 
Right and left CBFV as well as right and left BHI were 
correlated also for migraine subjects (Pearson’s correlation 
coefficient always greater than 0.9, p < 0.0001). 
 We considered as dependent variables the left and right 
CBFV. Multidimensional ANOVA tests were performed in 
order to extract the variables that influence the dependent 
variables. Mutation and the presence of aura were considered 
as factors. Among the variables (biochemical data) we 
removed all the variables with a correlation coefficient 
greater than 0.6. 
 We performed an outlier analysis using the Q and T
2
 
statistics. In processing the hematochemical and platelet-
related data, we found six outliers. However, we decided to 
keep them since they could be explanatory of pathology. 
When processing the instrumental data, we found four 
outliers relative to right CBFV (1 subject), left CBFV (2 
subjects), and right BHI (1 subject). Again, we preferred to 
keep such subjects in the database and note them in 
subsequent statistical analysis. 
2.2.2. Principal Component Analysis (PCA) 
 PCA is an unsupervised technique that effectively 
represents the information embedded in multidimensional 
data sets [23]. The raw data are represented in a transformed 
domain with lower dimensionality. The correlation structure 
of the raw data generates few latent variables (or principal 
components - PCs). PCs form an orthogonal basis and are 
sorted in order of decreasing explained data variance. Each 
PC can be expressed as 
 
PC = aX1 + bX2 + cX3 +…  where X1, 
X2, X3, … represent the measured features and a, b, c, … 
represent numerical weights. Each statistical unit is assigned 
a score relative to each extracted component, whereas the 
correlation coefficients between the original variables and 
the extracted components (loadings) furnish the significance 
of the specific PC. 
2.2.3. Partial Least Squares (PLS) 
 PLS is a supervised technique that aims at finding the 
better linear combination explaining experimental data. With 
reference to our study, we can define X  as the matrix 
containing the measured variables and Y  the matrix of the 
genetic mutation. Hence, X  contains the independent and 
Y  the dependent variables. The goal of PLS is to find the 
linear combination of X  that better explains Y . The initial 
linear model can be expressed as: 
Y = XB+E              (2) 
where B  is the regression coefficient matrix and E is the 
error matrix (same dimensions as Y). Given the difference in 
the numerical values of our data, we centered X and Y by 
subtracting their mean value and by normalizing with respect 
to their standard deviations. 
 When in presence of many collinear variables, PCA may 
fail in properly extracting the covariance structure between 
the predictors. Conversely, PLS only extracts the covariance 
structure between the predictors and the response variables, 
thus leading to a more reliable system description. The PLS 
defines a matrix T, so that T=XW; where W is an 
appropriate weight matrix and T is the factor score matrix. 
Then, the considered linear regression model becomes 
Y=TQ+E; where Q is the matrix of regression coefficients 
(loadings) for T, E is the error matrix. Once Q is calculated, 
the overall system is equivalent to the one in eq. (2), where 
B=WQ. This can now be used as a linear predictive 
regression model. Roughly, PLS can be thought as a PCA 
applied to the X matrix, a PCA applied to the Y matrix and 
the correlation analysis of the two sets of obtained PCs. 
 Using the standard NIPALS algorithm we performed all 
PLS numerical computations. 
2.2.4. Discriminant Analysis (DA) 
 Discriminant function analysis (DA) is used to determine 
which variables better discriminate between two or more 
occurring groups in the sample population. In our study, 
there are three natural groups, each one corresponding to 
genetic classification (no mutation, C/T677, and T/T677 
mutation). Computationally, DA determines a set of weight 
multiplying the X variables, so that the assignment error of 
each statistical unit to the correct Y class is minimized. We 
used PLS-DA to build a supervised model that could predict 
genetic mutation on the basis of patients’ instrumental and 
hematochemical data. 
 To build the classifier, the raw data set was split in two 
parts. Cross – validation was carried out it in order to avoid 
possible over fitting of the dataset given by the relatively 
small number of patients. We randomly selected 40 patients 
to build the classifier and we used the remaining 10 subjects 
for validation. We tested 100 different possible combinations 
of 40 (classifier set) and 10 (validation set) subjects, with the 
condition that in the validation subset there were at least 2 
subjects with C/T677 mutation, 2 with T/T677, and 2 with 
no mutation. We forced this condition since a preliminary 
study (results not reported in this paper) revealed that the 
classifier did not perform correctly when build on a 
heterogeneous subset and validated on a homogeneous one. 
Therefore, we only considered the random combinations 
leading to subsets in which all the three classes of subjects 
(no mutation, C/T677, and T/T677 mutation) were present. 
3. RESULTS 
 Table 3 reports the result of the multidimensional 
ANOVA analysis performed on the hematochemical and 
platelet-related data of Table 2 when considering the left and 
right CBFV as dependent variables. The principal factors 
were considered the presence of mutation and of aura. The 
CBFVs are influenced by response to ADP3 and collagen (p 
< 0.001). The left CBFV is also related to the respone to 
ristocetin (p < 0.001), whereas right CBFV is not. Between 
the principal factors, only mutation is related to blood 
velocity, whereas the presence of aura is not. The significant 
variables were used in the following unsupervised step to 
confirm relations between instrumental and biochemical 
data. 
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Table 3. ANOVA Results. Covariable Significance as 
Computed by ANOVA Analysis. Principal Factors 
are “Mutation” and “Aura” (Reported in Italics as 
Last Row of Each Dependent Variable). The 
Dependent Variables are the Left and Right CBFV 
(Listed in the First Column). The Second Column 
Reports the Name of the Significant Covariables and 
the Third Column Reports the Associated P Value 
 
Dependent Variable Covariable P Value 
ADP3 0.0040 
Collagen 0.0207 
Ristocetin 0.0340 
Mutation 0.0424 
Left CBFV 
Aura 0.5307 
ADP3 0.0021 
Collagen 0.0057 
Mutation 0.0230 
Right CBFV 
Aura 0.1553 
 
 PCA was performed on a data set consisting of the 50 
subjects (rows) and the following 7 observations: ADP3, 
collagen, ristocetin, right CBFV, left CBFV, right BHI and 
left BHI. All the variables were standardized. We extracted 3 
PCs; their combination explained 79.9% of the total variance 
of the data. Fig. (1) reports the graph of the seven 
eigenvalues. The eigenvalues are proportional to the percent 
of variability in the data they explain. We chose the 
eigenvalues greater than 1 (horizontal line in Fig. 1), since 
eigenvalues lower than 1 explain the same variance of the 
original variables, so they are not useful for data analysis in a 
reduced domain. 
 
Fig. (1). Eigenvalues of the PCA applied to the data set consisting 
of 7 variables (ADP3, collagen, ristocetin, right and left CBFV, 
right and left BHI). The first three eigenvalues are higher than 1 
(horizontal dashed line). Therefore, these three eigenvalues were 
used to represent the subjects in a reduced domain of three principal 
components. 
 Table 4 reports the weights of the seven variables on the 
three components. Both the CBFVs have a high weight in 
the first component, whereas the BHIs in second and third. 
Also, ristocetin, collagen, and ADP3 responses have a 
negative high weight in the third component. 
Table 4. PCA Components. Weights of the Seven Variables 
with Respect to the First Three Principal 
Components of the PCA Analysis 
 
Variable Component 1 Component 2 Component 3 
ADP3 -0.27 0.40 -0.45 
Collagen 0.13 0.18 -0.57 
Ristocetin -0.04 0.37 -0.41 
Left CBFV 0.60 -0.18 -0.21 
Right CBFV 0.59 -0.21 -0.22 
Right BHI 0.34 0.54 0.28 
Left BHI 0.27 0.55 0.35 
 
 Fig. (2) reports the subjects’ distribution on the hyperplanes 
formed by component 1 and 2 (uppermost graph), component 2 
and 3 (central graph), and component 1 and 3 (bottom graph). 
Black circles represent the subjects in the T/T677 group, gray 
circles those in the C/T677 group, and white circles those 
without mutation. The black continuous lines represent the 
projection of the original variables on the hyperplanes. The first 
component separates the subjects with T/T677 mutation from 
the subjects with C/T677 mutation or no mutation (Fig. 2, upper 
panel in the top right quadrant and bottom panel in the upper 
part of the chart). Component 2 separates the T/T677 mutation 
in the upper part of the chart (Fig. 2, middle panel). Table 5 
reports the result of the t-test performed on the mutation 
subgroups. Table 5 confirms that Component 1 differentiates 
T/T677 from C/T677, whereas Component 2 separates T/T677 
from C/T677 and from the subjects without mutation. 
Table 5. t-Test Comparing Different Mutations. Results of the 
t-Test Comparing the Three Mutation Subgroups. 
The Significance Threshold is 0.05. Asterisks Mark 
the Statistically Significant Differences. In 
Parenthesis, the Explained Variance by the Specific 
PCA Component 
 
Patient Groups 
Component 1 
(30.13) 
Component 2 
(27.31) 
Component 3 
(22.46) 
No mutation vs C/T677 0.805 -0.946 0.783 
No mutation vs T/T677 -1.459 -6.623* -5.075 
T/T677 vs C/T677 2.581* -5.075* -1.387 
 
 The overall result of PCA was that subjects with T/T677 
mutation might be distinguished from the other subjects 
because of their PC values. However, such PCs are mainly 
correlated to the CBFVs (first component), BHI (second and 
third component), collagen, ADP3, and ristocetin (third 
component). This result confirms the importance of the 
vascular parameters alterations carried by genetic mutations 
in migraine. 
 The analysis of the subjects with respect to mutation was 
refined by using PLS as supervised approach. Independent 
variables were same as PCA, dependent variables were  
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Fig. (2). PCA representation of the subjects in the three 
hyperplanes. Black circles represent the subjects in the T/T677 
group, gray circles those in the C/T677 group, and white circles 
those without mutation. The dashed lines represent the zero level of 
the principal components. The black lines represent the projection 
of the original variables on the hyperplanes. Upper panel: PC1 vs 
PC2. Central panel: PC3 vs PC2. Lower panel: PC3 vs PC1. 
mutation and aura. Table 6 summarizes the weights of the 
dependent and independent components. Fig. (3) reports the 
PLS discrimination of the subjects in the hyperplane (factor 
2, factor 4). Factor 2, in particular, is discriminant of the 
T/T677 (black circles – left part of the graph) and C/T677 
mutations (gray circles – right part of the graph). In 
particular, collagen responseis higher in the subjects without 
mutation with respect to T/T677 (t-test, p < 0.001) and in the 
subjects with C/T677 mutation with respect to T/T677 (t-
test, p < 0.002). 
 The supervised PLS-DA classifier was built by coding by 
a number (0 = no mutation; 1 = C/T677 mutation; 2 = 
T/T677 mutation) the dummy variable Y. To build the PLS-
DA classifier we relied on the previously performed 
ANOVA analysis and removed all the variables with a 
correlation coefficient higher than 0.6. This lead to remove 
the following four variables for the X matrix: antithrombin, 
PTinr, hematocrit, and erythrocytes. The classifier was 
developed on a set of 40 subjects (corpus set). Fig. (4) shows 
a sample of the discrimination of a corpus set performed by 
the first two functions. The black “+” (plus sign) mark the 
centroids of the clusters. In this specific case, sensitivity is 
100% and specificity is 100% (on the corpus set); the Wilks’ 
lambda parameter is equal to 0.071, leading to p < 0.003. 
 
Fig. (3). Sample PLS representation of the subjects in the 
hyperplane defined by Factor 2 and Factor 4 (factors are 
numerically reported by table VI). Black circles represent the 
subjects in the T/T677 group, gray circles those in the C/T677 
group, and white circles those without mutation. The dashed lines 
represent the zero level of the principal components. It can be 
observed that Factor 2 separates the genetic mutation T/T677 (left 
part of the chart – black circles) from the C/T677 (right part of the 
chart – gray circles). 
Table 6. PLS Factors. Weights for the Dependent and 
Independent Variables for the PLS Analysis 
 
Independent Variables Factor 1 Factor 2 Factor 3 Factor 4 
Aura 0.36 -0.15 0.41 0.07 
ADP3 -0.72 -0.41 -0.28 -0.18 
Collagen 0.51 0.54 -0.03 -0.29 
Ristocetin -0.04 0.40 0.40 -0.05 
Left BHI 0.01 -0.60 -0.29 -0.75 
Right BHI 0.32 0.02 0.72 0.55 
Dependent Variables Factor 1 Factor 2 Factor 3 Factor 4 
Left CBFV 0.50 0.29 0.24 0.22 
Right CBFV 0.52 0.28 0.10 0.22 
 
 
Fig. (4). Sample PLS-DA representation of the 40 subjects of a 
corpus set in the hyperplane defined by the discriminant Functions 
1 and 2. Black circles represent the subjects in the T/T677 group, 
gray circles those in the C/T677 group, and white circles those 
without mutation. The black “+” (plus sign) mark the centroids of 
the clusters. 
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 The PLS-DA classifier was then used to cluster the 
remaining 10 subjects (validation set). Corpus and validation 
sets were randomly selected. We tested 100 combinations 
leading to corpus and validation sets containing at least 2 
subjects for each group. Hence, we classified 1000 subjects, 
363 of which belonged to the T/T677 group, 364 to the 
C/T677 group, and 273 to the no mutation group. 
 Each element of the validation set was assigned to a 
group on the basis of its distance from the centroids. For all 
the considered classifiers, the discriminant function p-value 
were always lower than 0.01. The classification performance 
were (between brackets we indicated the range of variation): 
• 100% sensitivity (95.6% - 100%)and 97.6% 
specificity (94.1% - 98.3%) for the T/T677 mutation; 
• 91.8% sensitivity (87.5% - 95.5%) sensitivity and 
97.6% specificity (92.3% - 99.0%) for the C/T677 
mutation; 
• 89.0% sensitivity (84.7% - 92.4%) and 95.9% 
specificity (90.2% - 98.8%) for the group without 
mutation. 
 Overall classifier performance was 95.9% sensitivity, 
89.0% specificity, and 94.0% efficiency. 
4. DISCUSSION 
 Migraine is a complex neurological disorder involving 
different aspects, ranging from metabolic imbalances to 
neuronal and vascular anomalies. In this study, we profiled 
different groups of women suffering from migraine. The 
independent observation we considered in this study was the 
genetic mutation of the 677-MTHFR gene. We believe that, 
though preliminary, this study could be important in the 
clinical management of migraineurs. 
 We built a mixed database incorporating instrumental 
data (the CBFVs in the middle cerebral arteries and the 
cerebral reactivity index to BH), genetic data (the mutation 
type: C/T677 or T/T677, or the absence of mutation), and 
some biochemical parameters (including hematochemical 
variables and data related to platelet aggregation. The 
complete list is reported by Table 2). 
 PCA and multivariate ANOVA essentially pointed out 
that, in our sample population of migraine sufferers, 677-
MTHFR mutations are associated to altered platelet response 
to collagen, ristocetin, and ADP3. However, we also 
documented that the MTHFR mutations in migraine 
correlate with the instrumental measures of CBFVs and BHI. 
PLS results confirmed the importa-nce of the CBFVs and 
BHI patterns in the different subgroups of the genetic 
mutations (last four rows of Table 6). When compared to 
C/T677 subgroup, T/T677 subjects showed increased BHIs 
(t-test, p < 510-6 for left and p < 610-7 for the right side). 
 The PLS-DA offered satisfactory classification 
performance when classifying a population of migraineurs 
on the basis of their genetic mutation. The overall 
classification performance was 95.9% sensitivity and 89.0% 
specificity. The most important variables for classification 
were the left and right CBFVs, the BHI, and, again, the 
platelet response to ADP3, collagen, and ristocetin. This 
finding confirms the importance of assessing the 
vasculature-related variables in migraine. Therefore, we 
believe that TCD could be of primary importance also in the 
follow-up of migraine sufferers. 
 We found that the BHI is altered in subjects with genetic 
mutations (t-test, p < 510-6). This result confirms that 
vascular reactivity may be impaired in migraineurs [24]. In 
2008, Vernieri et al. showed that subjects suffering from 
MwA presented an increased BHI in the predominant 
migraine side with respect to non predominant and to control 
subjects [25], suggesting a possible deficit in the 
cerebrovascular autonomic control. 
 Our results are confirmatory of previously published 
studies. Novelty resides in two results that we obtained 
thanks to the applied multidimensional approach. First, we 
found that aura is not a major significant factor when related 
to mutation. In other words, the presence of aura was not 
correlated to the overall profile of the genetic mutation. This 
result is somehow new, since many studies pointed out that 
migraine with and without aura are characterized by different 
pathogenesis. Also, some pathologies have a greater 
prevalence in MwA than in migraine without aura (i.e., the 
patent foramen ovale [26]. We did not find any significant 
correlation between aura and the instrumental or biochemical 
variables. PCA and PLS showed that the metabolic profile of 
subjects with C/T677and T/T677 mutations is significantly 
different than subjects without mutation, even if aura is 
discarded among the classification variables. 
 The second important and novel result is that 
biochemical data alone are insufficient to perform 
classification. We tested a PLS-DA classifier based only on 
the variables of Table 2. Basically, we removed the 
instrumental data from the data matrix X. Performance 
dropped to 54% sensitivity and 58% specificity (p > 0.05). 
Mutation, therefore, induces a global alteration of the 
metabolic profile of the subject that is better described by the 
joint analysis of hematochemical and vascular parameters. 
 In developing the PLS-DA classifier, we removed all the 
collinear variables with correlation coefficient higher than 
0.6. We used this as stopping criterion for PLS regression. 
We tried to remove the variables with correlation coefficient 
higher than 0.5. In this case we deleted from the database 
five variables: antithrombin, PTinr, hematocrit, erythrocytes, 
and C protein. Classification performance was lower than in 
the former version: sensitivity was 90.1% and specificity 
was 85.2%. Therefore, we adopted 0.6 as threshold for 
assessing collinearity and for removing the co-variables. 
This result demonstrates the importance of a complete 
metabolic profiling for clustering MTHFR genetic mutations 
in migraine sufferers. 
 Finally, we did not perform outlier rejection. Being they 
outliers either for the biochemical variables or for the 
instrumental variables, outliers were correctly classified in 
all the tests we did. Therefore, we assumed that outliers 
might be representative of the variability of the data that can 
be obtained when working with a complex pathology like 
migraine. 
 The principal limitation of this study relies in the relative 
paucity of the sample database. However, results seem very 
promising since even the first multivariate analysis we 
performed (unsupervised PCA, Fig. 1) showed a natural 
tendency in clustering T/T677 mutations. The application of this 
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method corresponds to depicting a sort of ‘natural 
normalization’ of the studied data set, given that principal 
components correspond to the eigenvectors of the correlation 
matrix, which in turn corresponds by definition to the 
covariance matrix of the standardized variables. This is 
particularly convenient when dealing with heterogeneous 
variables defined by completely different measurement units, 
ruling out all questionable a priori defined standardization 
processes. Another limitation of the study is the small number 
of hematochemical data inserted into the database. We decided 
to develop a study based on exams that are routinely done. 
Therefore, we did not specifically test any hematochemical 
variable outside the list in Table 2 (first column), which 
somehow reflects is the list of blood examinations requested by 
the Institution where the patients are followed. 
 To the very best of our knowledge, this is the first 
attempt to use metabonomic statistical techniques applied to 
a clinical data set consisting of metabolic and instrumental 
data. We believe that this approach could constitute a pilot 
experience to bring metabolomic (and, in general, data 
mining) techniques into clinical practice, when tuned for 
specific and well-defined groups of patients. 
5. CONCLUSION 
 By using a metabonomic approach, we developed a 
classifier to detect genetic mutations of the 677-MTHFR 
gene in a population of women suffering from migraine. Our 
database consisted biochemical and instrumental data. 
Transcranial Doppler ultrasonography was used to measure 
the baseline values of the cerebral blood flow and their 
variation during voluntary breath – holding. Unsupervised 
and supervised approaches were used to extract the variables 
correlating to mutation. Our classifier showed overall 
satisfactory performance: 95.9% sensitivity and 89.0% 
specificity. We found that cerebral blood flow velocities and 
response to breath – holding are important variables in 
characterizing mutations in migraine. 
 This pilot study adapting metabonomic techniques to the 
profiling of pathologic subjects could be a basis for the 
development of a clinically applicable methodology devoted 
to the profiling, classification, and evolutionary modeling of 
migraine patients. 
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